American Journal of Cardiovascular Drugs

ISSN: 1175-3277• JCR: AM J CARDIOVASC DRUGAdis, Springer HealthcareSwitzerland
Visit Journal Homepage
3.0
2025 Impact Factor
2.7
5-Year Impact Factor
Q2
JCR Quartile
B4
CAS Block

American Journal of Cardiovascular Drugs impact factor and JCR quartile

The 2025 impact factor for American Journal of Cardiovascular Drugs is 3.0. The 5-year impact factor is 2.7. The journal is listed as JCR Q2 in the current Journal Metrics dataset.

Use this record to check the journal title, ISSN, JCR quartile, CAS block, publisher details, and similar journals before comparing publication venues.

If you searched for American Journal of Cardiovascular Drugs impact factor 2025, compare this exact title record with the journal homepage and nearby journals in the same field. That helps avoid mixing this journal with a similarly named title, abbreviation, society series, or outdated metric snippet.

2025 impact factor and source check

This page is designed for exact-title searches such as American Journal of Cardiovascular Drugs impact factor 2025. First confirm that the ISSN and title match this record before using the metric in a journal shortlist or submission decision.

For high-stakes submission decisions, verify the title against the publisher record at the journal homepage, Clarivate's Master Journal List or Journal Citation Reports if you have access, and the context in our methodology. Treat the 5-year impact factor, JCR quartile, article volume, and similar journals as supporting context rather than a single-number publication decision.

Journal Details

Total Articles
1,384
H-Index
72
Open Access
Hybrid
APC
$4,390 USD
Subject Areas
Cardiology and Cardiovascular MedicineSurgeryCardiology and Cardiovascular MedicineCardiology and Cardiovascular MedicineCardiology and Cardiovascular Medicine

Article Volume

2021
59
2022
42
2023
62
2024
91
2025
67
2026
12
Back to Search